Acute vascular response to cediranib treatment in human non-small-cell lung cancer xenografts with different tumour stromal architecture.

Lung Cancer · 2015 · PMC4641245 · PMID 26323213

Europe PMC DOI

hedged sentence

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

did not reach statistical significanceP = 0.07so close (0.05 < p ≤ 0.1)

4 B), it did not reach statistical significance ( P = 0.07). 4 Discussion It has been suggested that the vascular phenotypes of tumours categorised by stromal architecture can define tumour response to chronic VEGF-targeted monotherapy [14] .

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.